Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Painter

Showing results (141-150 of 181) with videos related to

Pageof 19
Sort By:
International Clinical Psychopharmacology|November 10, 2009
Fluoxetine-clonazepam cotherapy for anxious depression: an exploratory, post-hoc analysis of a randomized, double blind studyGeorge I Papakostas, Alisabet Clain, Victoria E Ameral, et al.
Journal of Virology|November 18, 2025
Pathogenesis of Hazara orthonairovirus infection in type I interferon receptor-deficient mice and resolution of disease following 4'-fluorouridine therapyJustin S Murray, Jonna B Westover, Dionna Scharton, et al.
Antimicrobial Agents and Chemotherapy|March 2, 2021
Human Safety, Tolerability, and Pharmacokinetics of Molnupiravir, a Novel Broad-Spectrum Oral Antiviral Agent with Activity Against SARS-CoV-2Wendy P Painter, Wayne Holman, Jim A Bush, et al.
Regulatory Toxicology and Pharmacology : RTP|August 1, 1992
On the carcinogenicity of cadmium by the oral routeJ F Collins, J P Brown, P R Painter, et al.
Antimicrobial Agents and Chemotherapy|November 27, 2019
Analysis of the Potential for <i>N</i><sup>4</sup>-Hydroxycytidine To Inhibit Mitochondrial Replication and FunctionZachary M Sticher, Gaofei Lu, Deborah G Mitchell, et al.
Antimicrobial Agents and Chemotherapy|May 5, 2010
Development of hexadecyloxypropyl tenofovir (CMX157) for treatment of infection caused by wild-type and nucleoside/nucleotide-resistant HIVE Randall Lanier, Roger G Ptak, Bernhard M Lampert, et al.
Antimicrobial Agents and Chemotherapy|November 29, 2017
Simple <i>In Vitro</i> Assay To Evaluate the Incorporation Efficiency of Ribonucleotide Analog 5'-Triphosphates into RNA by Human Mitochondrial DNA-Dependent RNA PolymeraseGaofei Lu, Gregory R Bluemling, Shuli Mao, et al.
Journal of Virology|January 15, 2026
Impact of mutations affecting 4'-fluorouridine susceptibility on fitness and treatment outcomes for Venezuelan equine encephalitis virusJenny Wong, Tahirah Moore, Devin Lewis, et al.
Brain Communications|August 21, 2024
Virtual reality gameplay classification illustrates the multidimensionality of visuospatial neglectDavid R Painter, Michael F Norwood, Chelsea H Marsh, et al.
Antimicrobial Agents and Chemotherapy|July 25, 2007
Evaluation of hexadecyloxypropyl-9-R-[2-(Phosphonomethoxy)propyl]- adenine, CMX157, as a potential treatment for human immunodeficiency virus type 1 and hepatitis B virus infectionsGeorge R Painter, Merrick R Almond, Lawrence C Trost, et al.
Pageof 19

Showing results (141-150 of 181) with videos related to

Sort By:
Pageof 19
International Clinical Psychopharmacology|November 10, 2009
Fluoxetine-clonazepam cotherapy for anxious depression: an exploratory, post-hoc analysis of a randomized, double blind studyGeorge I Papakostas, Alisabet Clain, Victoria E Ameral, et al.
Journal of Virology|November 18, 2025
Pathogenesis of Hazara orthonairovirus infection in type I interferon receptor-deficient mice and resolution of disease following 4'-fluorouridine therapyJustin S Murray, Jonna B Westover, Dionna Scharton, et al.
Antimicrobial Agents and Chemotherapy|March 2, 2021
Human Safety, Tolerability, and Pharmacokinetics of Molnupiravir, a Novel Broad-Spectrum Oral Antiviral Agent with Activity Against SARS-CoV-2Wendy P Painter, Wayne Holman, Jim A Bush, et al.
Regulatory Toxicology and Pharmacology : RTP|August 1, 1992
On the carcinogenicity of cadmium by the oral routeJ F Collins, J P Brown, P R Painter, et al.
Antimicrobial Agents and Chemotherapy|November 27, 2019
Analysis of the Potential for <i>N</i><sup>4</sup>-Hydroxycytidine To Inhibit Mitochondrial Replication and FunctionZachary M Sticher, Gaofei Lu, Deborah G Mitchell, et al.
Antimicrobial Agents and Chemotherapy|May 5, 2010
Development of hexadecyloxypropyl tenofovir (CMX157) for treatment of infection caused by wild-type and nucleoside/nucleotide-resistant HIVE Randall Lanier, Roger G Ptak, Bernhard M Lampert, et al.
Antimicrobial Agents and Chemotherapy|November 29, 2017
Simple <i>In Vitro</i> Assay To Evaluate the Incorporation Efficiency of Ribonucleotide Analog 5'-Triphosphates into RNA by Human Mitochondrial DNA-Dependent RNA PolymeraseGaofei Lu, Gregory R Bluemling, Shuli Mao, et al.
Journal of Virology|January 15, 2026
Impact of mutations affecting 4'-fluorouridine susceptibility on fitness and treatment outcomes for Venezuelan equine encephalitis virusJenny Wong, Tahirah Moore, Devin Lewis, et al.
Brain Communications|August 21, 2024
Virtual reality gameplay classification illustrates the multidimensionality of visuospatial neglectDavid R Painter, Michael F Norwood, Chelsea H Marsh, et al.
Antimicrobial Agents and Chemotherapy|July 25, 2007
Evaluation of hexadecyloxypropyl-9-R-[2-(Phosphonomethoxy)propyl]- adenine, CMX157, as a potential treatment for human immunodeficiency virus type 1 and hepatitis B virus infectionsGeorge R Painter, Merrick R Almond, Lawrence C Trost, et al.
Pageof 19